TVARDI THERAPEUTICS
Tvardi Therapeutics they are focused on the development of orally delivered, small molecule inhibitors of STAT3. They provide medicines for diverse cancers, chronic inflammatory diseases and fibrotic diseases.
TVARDI THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Service Industry
Founded:
2017-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.tvarditherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
832-413-1362
Total Funding:
81.42 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Wordpress Plugins
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arvinas
Arvinas focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, and autoimmune.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Koya Medical
Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Current Advisors List
Current Employees Featured
Founder
Investors List
683 CAPITAL
683 CAPITAL investment in Series B - Tvardi Therapeutics
Slate Path Capital
Slate Path Capital investment in Series B - Tvardi Therapeutics
Sporos Bioventures
Sporos Bioventures investment in Series B - Tvardi Therapeutics
ArrowMark Partners
ArrowMark Partners investment in Series B - Tvardi Therapeutics
Piedmont Capital Investments
Piedmont Capital Investments investment in Series B - Tvardi Therapeutics
Official Site Inspections
http://www.tvarditherapeutics.com
- Host name: secure.depinhodesign.com
- IP address: 104.247.77.142
- Location: Los Angeles United States
- Latitude: 33.956
- Longitude: -118.3887
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90045
